107,588 Shares in LifeStance Health Group, Inc. $LFST Purchased by Allianz Asset Management GmbH

Key Points

• Allianz Asset Management initiated a position in LifeStance Health Group, purchasing 107,588 shares valued at approximately $1.15 million. Institutional investors collectively own 85.5% of LFST.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $12.62; several firms recently raised their targets to between $13 and $15.
• LifeStance exceeded quarterly expectations, reporting $0.06 in adjusted EPS and $435.35 million in revenue, up 26.1% year over year. However, insiders sold roughly 14.7 million shares worth $155.5 million over the past three months.

Allianz Asset Management GmbH bought a new stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 107,588 shares of the company's stock, valued at approximately $1,152,000.

A number of other large investors have also recently bought and sold shares of LFST. Assetmark Inc. increased its stake in LifeStance Health Group by 17.0% in the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company's stock valued at $60,000 after buying an additional 1,367 shares during the last quarter. California State Teachers Retirement System increased its position in shares of LifeStance Health Group by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 125,682 shares of the company's stock valued at $885,000 after acquiring an additional 1,966 shares during the last quarter. Vident Advisory LLC grew its stake in LifeStance Health Group by 12.7% in the second quarter. Vident Advisory LLC now owns 21,732 shares of the company's stock valued at $112,000 after purchasing an additional 2,447 shares in the last quarter. Xponance LLC boosted its holdings in shares of LifeStance Health Group by 26.4% in the 4th quarter. Xponance LLC now owns 13,144 shares of the company's stock valued at $93,000 after buying an additional 2,745 shares during the last quarter. Finally, Diversified Trust Co boosted its holdings in shares of LifeStance Health Group by 14.8% in the 1st quarter. Diversified Trust Co now owns 21,532 shares of the company's stock valued at $137,000 after buying an additional 2,770 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company's stock.

Wall Street Analyst Weigh In

LFST has been the subject of a number of analyst reports. Wall Street Zen downgraded shares of LifeStance Health Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday, September 5th. Barclays raised their target price on shares of LifeStance Health Group from $9.00 to $13.00 and gave the company an "overweight" rating in a research note on Tuesday, July 14th. JPMorgan Chase & Co. upped their price objective on LifeStance Health Group from $9.00 to $13.00 and gave the company a "neutral" rating in a research note on Friday, August 14th. Canaccord Genuity Group raised their price target on LifeStance Health Group from $13.00 to $15.00 and gave the company a "buy" rating in a report on Wednesday. Finally, KeyCorp lifted their price objective on shares of LifeStance Health Group from $11.00 to $13.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $12.62.

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $12.62 on Thursday. The business has a fifty day moving average price of $11.60 and a two-hundred day moving average price of $8.93. The stock has a market capitalization of $4.89 billion, a PE ratio of 97.08 and a beta of 1.22. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38. LifeStance Health Group, Inc. has a fifty-two week low of $4.77 and a fifty-two week high of $13.15.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.06 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.03. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The company had revenue of $435.35 million for the quarter, compared to analysts' expectations of $414.58 million. During the same quarter last year, the business earned ($0.01) earnings per share. LifeStance Health Group's revenue was up 26.1% on a year-over-year basis. As a group, equities analysts predict that LifeStance Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Insider Activity

In other LifeStance Health Group news, CTO Vukasin Paunovich sold 44,394 shares of the company's stock in a transaction on Monday, August 10th. The stock was sold at an average price of $10.85, for a total transaction of $481,674.90. Following the completion of the sale, the chief technology officer directly owned 247,446 shares in the company, valued at $2,684,789.10. This represents a 15.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the firm's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $10.62, for a total value of $144,890,858.34. Following the completion of the sale, the insider directly owned 98,101,407 shares in the company, valued at approximately $1,041,836,942.34. This represents a 12.21% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 14,671,917 shares of company stock valued at $155,493,415 in the last three months. Company insiders own 3.50% of the company's stock.

LifeStance Health Group Profile

LifeStance Health Group NASDAQ: LFST is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.